Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
-
A3424 Gambogic AcidSummary: Caspase activator and apoptosis inducer
-
A4419 Ac-LEHD-AFCSummary: Fluorogenic caspase substrate
-
A1901 Q-VD-OPh53 CitationTarget: CaspasesSummary: Cell-permeable, irreversible pan-caspase inhibitor
-
A1904 Boc-D-FMK1 CitationTarget: CaspasesSummary: Pan-caspase inhibitor
-
A1920 Z-DEVD-FMK12 CitationTarget: CaspasesSummary: Caspase-3 inhibitor
-
A1921 Z-DQMD-FMK3 CitationTarget: CaspasesSummary: Caspase-3 inhibitor,cell-permeable
-
A1922 Z-VDVAD-FMKSummary: Caspase-2 inhibitor
-
A1923 Z-VEID-FMK2 CitationTarget: CaspasesSummary: Caspase-6 inhibitor
-
A1924 Z-WEHD-FMK1 CitationSummary: Caspase 5 inhibitor,potent,cell-permeable and irreversible
-
A1925 Caspase-3/7 Inhibitor I2 CitationTarget: CaspasesSummary: Caspase-3/7 inhibitor